Multinational pharmaceutical and biotechnology corporation Pfizer, has entered the medical cannabis industry, signing a contract with the clinical-stage company Arena Pharmaceuticals. Arena Pharmaceuticals has developed an up-and-coming cannabinoid-based bowel disease treatment. Pfizer’s Global President of Inflammation and Immunization and Immunology explained, “The proposed acquisition of Arena complements our capabilities and expertise in Inflammation and Immunology, […]